Literature DB >> 30585381

Oxytocin inhibits methamphetamine-associated learning and memory alterations by regulating DNA methylation at the Synaptophysin promoter.

Xin-Yu Fan1, Jing-Yu Yang1, Ying-Xu Dong1, Ying Hou1, Shuai Liu1, Chun-Fu Wu1.   

Abstract

Methamphetamine (METH) causes memory changes, but the underlying mechanisms are poorly understood. Epigenetic mechanisms, including DNA methylation, can potentially cause synaptic changes in the brain. Oxytocin (OT) plays a central role in learning and memory, but little is known of the impact of OT on METH-associated memory changes. Here, we explored the role of OT in METH-induced epigenetic alterations that underlie spatial and cognitive memory changes. METH (2.0 mg/kg, i.p.) was administered to male C57BL/6 mice once every other day for 8 days. OT (2.5 μg, i.c.v.) or aCSF was given prior to METH. Spatial and cognitive memory were assessed. In Hip and PFC, synaptic structures and proteins were examined, levels of DNA methyltransferases (DNMTs) and methyl CpG binding protein 2 (MECP2) were determined, and the DNA methylation status at the Synaptophysin (Syn) promoter was assessed. METH enhanced spatial memory, decreased synapse length, downregulated DNMT1, DNMT3A, DNMT3B, and MECP2, and induced DNA hypomethylation at the Syn promoter in Hip. In contrast, METH reduced cognitive memory, increased synapse thickness, upregulated DNMT1, DNMT3A, and MECP2, and induced DNA hypermethylation at the Syn promoter in PFC. OT pretreatment specifically ameliorated METH-induced learning and memory alterations, normalized synapse structures, and regulated DNMTs and MECP2 to reverse the DNA methylation status changes at the Syn promoter in Hip and PFC. DNA methylation is an important gene regulatory mechanism underlying METH-induced learning and memory alterations. OT can potentially be used to specifically manipulate METH-related memory changes.
© 2018 Society for the Study of Addiction.

Entities:  

Keywords:  DNA methylation; DNA methyltransferase; methamphetamine; methyl CpG binding protein 2; oxytocin; synaptophysin

Mesh:

Substances:

Year:  2018        PMID: 30585381     DOI: 10.1111/adb.12697

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  4 in total

Review 1.  DNA Epigenetics in Addiction Susceptibility.

Authors:  Graham Kaplan; Haiyang Xu; Kristen Abreu; Jian Feng
Journal:  Front Genet       Date:  2022-01-25       Impact factor: 4.599

Review 2.  Epigenetic mechanisms involved in methamphetamine addiction.

Authors:  Hang Wang; Xianghuan Dong; Maher Un Nisa Awan; Jie Bai
Journal:  Front Pharmacol       Date:  2022-08-26       Impact factor: 5.988

3.  Cannabidiol prevents methamphetamine-induced neurotoxicity by modulating dopamine receptor D1-mediated calcium-dependent phosphorylation of methyl-CpG-binding protein 2.

Authors:  Baoyu Shen; Ruilin Zhang; Genmeng Yang; Yanxia Peng; Qianyun Nie; Hao Yu; Wenjuan Dong; Bingzheng Chen; Chunhui Song; Yan Tian; Lixiang Qin; Junjie Shu; Shijun Hong; Lihua Li
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

4.  Genome-Wide DNA Methylation Analysis in Male Methamphetamine Users With Different Addiction Qualities.

Authors:  Liang Liu; Tao Luo; Huixi Dong; Chenxi Zhang; Tieqiao Liu; Xiangyang Zhang; Wei Hao
Journal:  Front Psychiatry       Date:  2020-10-23       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.